|
1
|
Mielcarek M, Storer B, Martin PJ, Forman
SJ, Negrin RS, Flowers ME, Inamoto Y, Chauncey TR, Storb R,
Appelbaum FR and Bensinger WI: Long-term outcomes after
transplantation of HLA-identical related G-CSF-mobilized peripheral
blood mononuclear cells versus bone marrow. Blood. 119:2675–2678.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morecki S, Yacovlev E, Gelfand Y, Shabat Y
and Slavin S: Induction of graft-versus-leukemia (GVL) effect
without graft-versus-host disease (GVHD) by pretransplant donor
treatment with immunomodulators. Biol Blood Marrow Transplant.
15:406–415. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Edinger M, Powrie F and Chakraverty R:
Regulatory mechanisms in graft-versus- host response. Biol Blood
Marrow Transplant. 15(1 Suppl): 2–6. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang Y, Feng S, Tang R, Du B, Xu K and
Pan X: Efficacy of pretreatment of allografts with
methoxypolyethylene glycol-succinimidyl-propionic acid ester in
combination with an anti-OX40L monoclonal antibody in relieving
graft-versus-host disease in mice. Int J Hematol. 92:609–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sordi V and Piemonti L: Therapeutic
plasticity of stem cells and allograft tolerance. Cytotherapy.
13:647–660. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou F, Ciric B, Zhang GX and Rostami A:
Immune tolerance induced by intravenous transfer of immature
dendritic cells via up-regulating numbers of suppressive IL-10(+)
IFN-γ(+)-producing CD4(+) T cells. Immunol Res. 56:1–8. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cools N, Van Tendeloo VF, Smits EL, Lenjou
M, Nijs G, Van Bockstaele DR, Berneman ZN and Ponsaerts P:
Immunosuppression induced by immature dendritic cells is mediated
by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. J Cell
Mol Med. 12:690–700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun X, Jones HP, Dobbs N, Bodhankar S and
Simecka JW: Dendritic cells are the major antigen presenting cells
in inflammatory lesions of murine Mycoplasma respiratory disease.
PLoS One. 8:e559842013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maldonado RA and von Andrian UH: How
tolerogenic dendritic cells induce regulatory T cells. Adv Immunol.
108:111–165. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fukaya T, Takagi H, Taya H and Sato K: DCs
in immune tolerance in steady-state conditions. Methods Mol Biol.
677:113–126. 2011. View Article : Google Scholar
|
|
11
|
Trevejo JM, Marino MW, Philpott N, Josien
R, Richards EC, Elkon KB and Falck-Pedersen E: TNF-α-dependent
maturation of local dendritic cells is critical for activating the
adaptive immune response to virus infection. Proc Natl Acad Sci
USA. 98:12162–12167. 2001. View Article : Google Scholar
|
|
12
|
Kleijwegt FS, Laban S, Duinkerken G,
Joosten AM, Zaldumbide A, Nikolic T and Roep BO: Critical role for
TNF in the induction of human antigen-specific regulatory T cells
by tolerogenic dendritic cells. J Immunol. 185:1412–1418. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin JO, Park HY, Xu Q, Park JI,
Zvyagintseva T, Stonik VA and Kwak JY: Ligand of scavenger receptor
class A indirectly induces maturation of human blood dendritic
cells via production of tumor necrosis factor-alpha. Blood.
113:5839–5847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bosè F, Raeli L, Garutti C, et al: Dual
role of anti-TNF therapy: enhancement of TCR-mediated T cell
activation in peripheral blood and inhibition of inflammation in
target tissues. Clin Immunol. 139:164–176. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baldwin HM, Ito-Ihara T, Isaacs JD and
Hilkens CM: Tumour necrosis factor alpha blockade impairs dendritic
cell survival and function in rheumatoid arthritis. Ann Rheum Dis.
69:1200–1207. 2010. View Article : Google Scholar
|
|
16
|
Rossol M, Meusch U, Pierer M, Kaltenhäuser
S, Häntzschel H, Hauschildt S and Wagner U: Interaction between
transmembrane TNF and TNFR1/2 mediates the activation of monocytes
by contact with T cells. J Immunol. 179:4239–4248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi HJ and Lu GX: Adherent and non-adherent
dendritic cells are equivalently qualified in GM-CSF, IL-4 and
TNF-α culture system. Cell Immunol. 277:44–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia Y, Dai J, Lu P, Huang Y, Zhu Y and
Zhang X: Distinct effect of CD40 and TNF-signaling on the
chemokine/chemokine receptor expression and function of the human
monocyte-derived dendritic cells. Cell Mol Immunol. 5:121–131.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang YH, Chao YL, Tang RX, Wang SH, Zeng
LY, Chen C, Pan XY and Xu KL: Lentivirus-mediated soluble tumor
necrosis factor receptor 1 expression in mouse bone marrow-derived
immature dendritic cells. J Clin Rehabil Tissue Eng Res.
14:941–946. 2010.
|
|
20
|
Cao J, Chen C, Zeng L, Li L, Li Z and Xu
K: Engineered regulatory T cells prevent graft-versus-host disease
while sparing the graft-versus-leukemia effect after bone marrow
transplantation. Leuk Res. 34:1374–1382. 2010. View Article : Google Scholar
|
|
21
|
Cooke KR, Kobzik L, Martin TR, Brewer J,
Delmonte J Jr, Crawford JM and Ferrara JL: An experimental model of
idiopathic pneumonia syndrome after bone marrow transplantation: I.
The roles of minor H antigens and endotoxin. Blood. 88:3230–3239.
1996.PubMed/NCBI
|
|
22
|
Asai O, Longo DL, Tian ZG, Hornung RL,
Taub DD, Ruscetti FW and Murphy WJ: Suppression of
graft-versus-host disease and amplification of graft-versus-tumor
effects by activated natural killer cells after allogeneic bone
marrow transplantation. J Clin Invest. 101:1835–1842. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun K, Wilkins DE, Anver MR, Sayers TJ,
Panoskaltsis-Mortari A, Blazar BR, Welniak LA and Murphy WJ:
Differential effects of proteasome inhibition by bortezomib on
murine acute graft-versus-host disease (GVHD): delayed
administration of bortezomib results in increased GVHD-dependent
gastrointestinal toxicity. Blood. 106:3293–3299. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Appelbaum FR: Haematopoietic cell
transplantation as immunotherapy. Nature. 411:385–389. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Konuma T, Kato S, Ooi J, Oiwa-Monna M,
Kawamata T, Tojo A and Takahashi S: Comparable long-term outcome of
unrelated cord blood transplantation with related bone marrow or
peripheral blood stem cell transplantation in patients aged 45
years or older with hematologic malignancies after myeloablative
conditioning. Biol Blood Marrow Transplant. 20:1150–1155. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Besien K: Allogeneic transplantation
for AML and MDS: GVL versus GVHD and disease recurrence. Hematology
Am Soc Hematol Educ Program. 2013:56–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sinkovics JG: Antileukemia and antitumor
effects of the graft-versus-host disease: a new immunovirological
approach. Acta Microbiol Immunol Hung. 57:253–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ,
Min CK, Lee S, Cho SG, Jin JY, Lee JW and Kim CC: Successful
prevention of acute graft-versus-host disease using low-dose
antithymocyte globulin after mismatched, unrelated, hematopoietic
stem cell transplantation for acute myelogenous leukemia. Biol
Blood Marrow Transplant. 15:704–717. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Capitini CM, Herby S, Milliron M, Anver
MR, Mackall CL and Fry TJ: Bone marrow deficient in IFN-{gamma}
signaling selectively reverses GVHD-associated immunosuppression
and enhances a tumor-specific GVT effect. Blood. 113:5002–5009.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chorny A, Gonzalez-Rey E, Fernandez-Martin
A, Ganea D and Delgado M: Vasoactive intestinal peptide induces
regulatory dendritic cells that prevent acute graft-versus-host
disease while maintaining the graft-versus-tumor response. Blood.
107:3787–3794. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stenger EO, Turnquist HR, Mapara MY and
Thomson AW: Dendritic cells and regulation of graft-versus-host
disease and graft-versus-leukemia activity. Blood. 119:5088–5103.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Semple K, Yu Y, Wang D, Anasetti C and Yu
XZ: Efficient and selective prevention of GVHD by antigen-specific
induced Tregs via linked-suppression in mice. Biol Blood Marrow
Transplant. 17:309–318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Toubai T, Mathewson N and Reddy P: The
role of dendritic cells in graft-versus-tumor effect. Front
Immunol. 5:662014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun W, Wang Q, Zhang L, Pan J, Zhang M, Lu
G, Yao H, Wang J and Cao X: TGF-beta(1) gene modified immature
dendritic cells exhibit enhanced tolerogenicity but induce
allograft fibrosis in vivo. J Mol Med (Berl). 80:514–523. 2002.
View Article : Google Scholar
|
|
35
|
Sela U, Olds P, Park A, Schlesinger SJ and
Steinman RM: Dendritic cells induce antigen specific regulatory T
cells that prevent graft versus host disease and persist in mice. J
Exp Med. 208:2489–2496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang YG, Sergio JJ, Pearson DA, Szot GL,
Shimizu A and Sykes M: Interleukin-12 preserves the
graft-versus-leukemia effect of allogeneic CD8 T cells while
inhibiting CD4-dependent graft-versus-host disease in mice. Blood.
90:4651–4660. 1997.PubMed/NCBI
|
|
37
|
Mapara MY and Sykes M: Induction of mixed
vs full chimerism to potentiate GVL effects after bone-marrow
transplantation. Methods Mol Med. 109:469–474. 2005.
|
|
38
|
Li YJ, Cao J, Chen C, et al: Establishment
and identification of mouse lymphoma cell line EL4 expressing red
fluorescent protein. J Exp Hematol. 18:107–110. 2010.(In
Chinese).
|
|
39
|
Ball LM and Egeler RM; EBMT Paediatric
Working Party. Acute GvHD: pathogenesis and classification. Bone
Marrow Transplant. 41(Suppl 2): S58–S64. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun Y, Tawara I, Toubai T and Reddy P:
Pathophysiology of acute graft-versus-host disease: recent
advances. Transl Res. 150:197–214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Coghill JM, Sarantopoulos S, Moran TP,
Murphy WJ, Blazar BR and Serody JS: Effector CD4+ T cells, the
cytokines they generate, and GVHD: something old and something new.
Blood. 117:3268–3276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li JM, Giver CR, Lu Y, Hossain MS, Akhtari
M and Waller EK: Separating graft-versus-leukemia from
graft-versus-host disease in allogeneic hematopoietic stem cell
transplantation. Immunotherapy. 1:599–621. 2009.
|
|
43
|
Li X, Yang A, Huang H, et al: Induction of
type 2 T helper cell allergen tolerance by IL-10-differentiated
regulatory dendritic cells. Am J Respir Cell Mol Biol. 42:190–199.
2010. View Article : Google Scholar
|
